BIOMARKER FOR MONITORING OR DIAGNOSING ONSET OF LIVER CANCER IN HIGH-RISK GROUP FOR LIVER CANCER AND USES THEREOF

• 1. 肝癌高危人群的肝癌发病监视或诊断用生物标记物及其用途 [P] . 中国专利： CN110914689A . 2020-03-24
• 2. 一种肝癌诊断标志物、检测引物、试剂盒及肝癌诊断标志物的用途 [P] . 中国专利： CN109797222A . 2019-05-24
• 3. BIOMARKER FOR MONITORING OR DIAGNOSING ONSET OF LIVER CANCER IN HIGH-RISK GROUP FOR LIVER CANCER AND USE THEREOF [P] . 欧洲知识产权局专利： EP3623814A2 . 2020-03-18

  机译： 肝癌高危人群中肝癌的监测或诊断生物标志物及其用途

• 4. BIOMARKER FOR MONITORING OR DIAGNOSING ONSET OF LIVER CANCER IN HIGH-RISK GROUP FOR LIVER CANCER AND USE THEREOF [P] . 世界知识产权组织专利： WO2018208091A3 . 2019-01-03

  机译： 肝癌高危人群中肝癌的监测或诊断生物标志物及其用途

• 5. BIOMARKER FOR MONITORING OR DIAGNOSING ONSET OF LIVER CANCER IN HIGH-RISK GROUP FOR LIVER CANCER AND USE THEREOF [P] . 世界知识产权组织专利： WO2018208091A2 . 2018-11-15

  机译： 肝癌高危人群中肝癌的监测或诊断生物标志物及其用途

• 1. The re-emergence of the GP73 and fucosylated liver cancer biomarkers [J] . Block Timothy 工程科学（英文版） . 2014,第004期
• 2. Investigation of Plasma cell‐free cancer genome chromosomal instability as a tool for targeted minimally invasive biomarkers for primary liver cancer diagnoses [J] . Shuang Feng, Zhiwen Ding, Jin Wang, Cancer Medicine . 2020,第14期
• 3. Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer [J] . Gao Shiyong, Gang Jian, Yu Miao, BMC Cancer . 2021,第1期
• 4. CancerLivER: a database of liver cancer gene expression resources and biomarkers [J] . Harpreet Kaur, Sherry Bhalla, Dilraj Kaur, Database . 2020,第1期
• 5. UHPLC-QTOF Based Metabolomics for discovering Etiological Biomarkers of Liver Cancers Using Serum Samples from a Large Multinational Prospective Cohort [C] . Dinesh Barupal, Augustin Scalbert, Talita Duarte-Salles, International Mass Spectrometry Conference . 2014
• 6. Nanotechnology for efficient delivery of short therapeutic oligonucleotides (antisense ODN and siRNA) and codelivery with chemical anticancer drugs for effective cancer therapy [D] . Chen, Minhua 2009
• 7. Investigation of Plasma cell‐free cancer genome chromosomal instability as a tool for targeted minimally invasive biomarkers for primary liver cancer diagnoses [O] . Shuang Feng, Zhiwen Ding, Jin Wang, 2020
• 8. The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients’ Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers [O] . Soo Young Jun, Hyang Ran Yoon, Ji-Yong Yoon, 2021

• 1. Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers [J] . Dong-Xing Cao ,Zhi-Jie Li ,Xiao-Ou Jiang . 世界胃肠病学杂志：英文版 . 2012,第30期
• 2. PROGRESS IN LIVER CANCER RESEARCH IN CHINA: A SUMMARY OF THE FOURTH NATIONAL CONFERENCE OF THE SOCIETY OF LIVER CANCER, CHINA ANTI-CANCER ASSOCIATION [J] . 任正刚 . 中国癌症研究：英文版 . 2000,第1期
• 3. Challenges of liver cancer:Future emerging tools in imaging and urinary biomarkers [J] . Francesca M Trovato ,Joshua M Tognarelli ,Mary ME Crossey . 世界肝病学杂志：英文版（电子版） . 2015,第26期
• 4. The re-emergence of the GP73 and fucosylated liver cancer biomarkers [J] . Block Timothy . 中国工程科学 . 2014,第004期
• 5. 克拉玛依地区肝癌高危人群监测对肝癌早期诊断的对比分析 [C] . 唐焱 ,沈彬华 ,钱丽娟 . 中国抗癌协会临床肿瘤学协作中心第五届学术年会 . 2001
• 6. 小肝癌新血清标志物的筛选及其诊断价值评价及肝癌发病年龄相关临床流行病学因素调查 [A] . 王玉琪 . 2020